U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07425171) titled 'Safety and Effectiveness of GENOSS PCB in Patients With Long Femoropopliteal Lesion' on Feb. 12.
Brief Summary: The purpose of this study is to evaluate the long-term safety and efficacy of GENOSS PCB in patients with long femoropopliteal lesions who underwent percutaneous transluminal angioplasty using GENOSS PCB.
Study Start Date: Feb. 24
Study Type: OBSERVATIONAL
Condition:
PTA (Percutaneous Transluminal Angioplasty)
Femoropopliteal Artery Disease
Long Femoropopliteal Artery Disease
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Genoss Co., Ltd.
Disclaimer: Curated by HT Syndication....